MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Brain metabolic patterns in progressive supranuclear palsy phenotypes

    M.M. Carmona-Abellan, A. Fontes, E. Prieto, J. Arbizu, R. Luquin, M. Riverol (Pamplona, Spain)

    Objective: To describe changes in cerebral glucose metabolism in patients with different described clinical phenotypes of PSP and to correlate them with the clinical manifestations of the disease. Background:…
  • 2017 International Congress

    Serum Mir-30c as a Potential Biomarker to Discriminate MSA from PD Patients: A Pilot Study.

    A. Vallelunga, M. Sessa, D. Giovanna, M. Picillo, P. Barone, M.T. Pellecchia (Salerno, Italy)

    Objective: In this pilot study we evaluated  serum mir-30c levels in MSA and  PD patients, to assess if mir-30c can be useful to distinguish these…
  • 2017 International Congress

    Semiquantitative analyses of DAT-SPECT imaging with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism

    N. Morimoto, M. Takamiya, M. Morimoto (Takamatsu, Japan)

    Objective: We investigate the usefulness Dopamine transporter (DAT)-SPECT with an automated striatal analysis software in differential diagnosis of neurodegenerative parkinsonism. Background: DAT-SPECT imaging is sensitive…
  • 2017 International Congress

    Movement disorders caused by benign brain tumor

    A.M. Magnerou, P.E. Sounga Bandzouzi, H.F. Ngoungoure, M.M. Ndiaye (DAKAR, Senegal)

    Objective: Describe unusual etiology of movement disorders (MD). Background: Benign brain tumor can be manifested by MD. The clinical description and role of brain imaging…
  • 2017 International Congress

    Parkinsonism Revealing Cerebral Hematoma with Moya Moya Disease

    z. brahem, i. bedoui, a. riahi, m. mansour, j. zaouali, r. mrissa (tunis, Tunisia)

    Objective: The aim of this study is to describe a rare cause of parkinsonism. Background: Moyamoya disease (MMD), a rare chronic, progressive cerebrovascular disease leads…
  • 2017 International Congress

    Psychosocial Impact of X-Linked Dystonia Parkinsonism (XDP) of Panay

    J.N. Ong, C. Go, G. Solinap, P. Acuna (Manila, Philippines)

    Objective: The study will determine the patient’s quality of life and their subjective psychological well-being by using the Parkinson Disease Questionnaire (PDQ) - 39 and the World Health…
  • 2017 International Congress

    The secular change of quality of life in patients with Parkinson’s disease.

    A. Kumon, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

    Objective: To examine the secular change of quality of life (QOL) in patients with Parkinson's disease (PD). To clarify the correlated factor with QOL in…
  • 2017 International Congress

    Focused neuromodulation by short pulse width improves gait ataxia in thalamic DBS

    M. Reich, N. Pozzi, G. Brandt, A. Leporini, C. Palmisano, R. Lehrke, J. Volkmann, I. Isaias (Würzburg, Germany)

    Objective: To investigate the efficacy of selective neuromodulation to overcome stimulation-induced gait ataxia in patients with essential tremor (ET) and thalamic deep brain stimulation (DBS).…
  • 2017 International Congress

    Correspondence between MRI borders of the subthalamic nucleus and its electrophysiological borders: a comparison study using intraoperative CT.

    S. Bus, P. Van den Munckhof, M. Bot, G. Pal, B. Ouyang, S. Sani, L. Verhagen-Metman (Chicago, IL, USA)

    Objective: To compare dorsal and ventral subthalamic nucleus (STN) borders as seen on 3-Tesla (3T) T2-weighted (T2) and Susceptibility Weighted Images (SWI) with borders obtained…
  • 2017 International Congress

    Maximising decrease in Dopaminergic drugs and increase in ON time following Bilateral STN DBS using constant current for Advanced Parkinsons Disease

    S. SANYAL (CALCUTTA (KOLKATA), India)

    Objective: To evaluate the decrease in Dopaminergic drug dosage and increase in ON time following Bilateral STN DBS using constant current for Advanced PD Background:…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley